Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit)

v3.22.2.2
Condensed Consolidated Statements Of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Merger
Common Stock warrants
Sponsor Shares
Adjusted balance
Common Stock
Common Stock
Merger
Common Stock warrants
Common Stock
Sponsor Shares
Common Stock
Adjusted balance
Additional Paid-in Capital
Additional Paid-in Capital
Merger
Common Stock warrants
Additional Paid-in Capital
Sponsor Shares
Additional Paid-in Capital
Adjusted balance
Other Comprehensive Income
Other Comprehensive Income
Adjusted balance
Accumulated Deficit
Accumulated Deficit
Adjusted balance
Balance at beginning of period at Dec. 31, 2020       $ (32,813)       $ 3       $ 191,168   $ 0   $ (223,984)
Balance at beginning of period (in shares) at Dec. 31, 2020               34,692,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation $ 508               $ 508              
Issuance of common stock due to Bridge Notes 103,724       $ 2       103,722              
Issuance of common stock due to Bridge Notes (in shares)         20,029,000                      
Issuance of common stock upon exercise of stock options (in shares)         468,000                      
Issuance of common stock upon exercise of stock options 1               1              
Issuance of common stock upon vesting of restricted stock awards (in shares)         171,000                      
Issuance of common stock on conversion (in shares)         1,095,000                      
Issuance of common stock on conversion 120               120              
Other comprehensive income (loss) 1,389                       $ 1,389      
Net loss (168,556)                           $ (168,556)  
Balance at end of period at Mar. 31, 2021 (95,627)       $ 5       295,519       1,389   (392,540)  
Balance at end of period (in shares) at Mar. 31, 2021         56,455,000                      
Balance at beginning of period at Dec. 31, 2020       $ (32,813)       $ 3       $ 191,168   $ 0   $ (223,984)
Balance at beginning of period (in shares) at Dec. 31, 2020               34,692,000                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Repurchase and retirement of common stock 0                              
Other comprehensive income (loss) 0                              
Net loss (251,038)                              
Balance at end of period at Sep. 30, 2021 152,797       $ 11       629,090       0   (476,304)  
Balance at end of period (in shares) at Sep. 30, 2021         113,324,000                      
Balance at beginning of period at Mar. 31, 2021 (95,627)       $ 5       295,519       1,389   (392,540)  
Balance at beginning of period (in shares) at Mar. 31, 2021         56,455,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation 264               264              
Issuance of common stock due to Bridge Notes Rights Offering 2,629               2,629              
Issuance of common stock due to rights offering (in shares)         314,000                      
Issuance of common stock upon exercise of stock options (in shares)         210,000                      
Issuance of common stock upon exercise of stock options 6               6              
Issuance of common stock upon vesting of restricted stock awards (in shares)         130,000                      
Issuance of common stock upon vesting of restricted stock units (in shares)         34,000                      
Other comprehensive income (loss) (1,930)                       (1,930)      
Net loss (35,585)                           (35,585)  
Balance at end of period at Jun. 30, 2021 (130,243)       $ 5       298,418       (541)   (428,125)  
Balance at end of period (in shares) at Jun. 30, 2021         57,143,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation 28,493               28,493              
Issuance of common stock upon exercise of stock options (in shares)         290,000                      
Issuance of common stock upon exercise of stock options 93               93              
Issuance of common stock upon exercise of warrants, inclusive of preferred stock warrants exercised then converted to common stock in connection with the merger (in shares)         2,156,000                      
Issuance of common stock upon exercise of warrants, inclusive of preferred stock warrants exercised then converted to common stock in connection with the merger 2,169               2,169              
Issuance of common stock upon vesting of restricted stock awards (in shares)         160,000                      
Issuance of common stock upon vesting of restricted stock units (in shares)         68,000                      
Issuance of common stock on conversion (in shares)           11,187,000 7,736,000                  
Issuance of common stock on conversion   $ 38,329 $ 77,097     $ 1 $ 1     $ 38,328 $ 77,096          
Issuance of Sponsor Shares (17,659)               (17,659)              
Reverse recapitalization, net (in shares)         34,584,000                      
Reverse recapitalization, net 200,874       $ 4       202,152           (1,282)  
Other comprehensive income (loss) 541                       541      
Net loss (46,897)                           (46,897)  
Balance at end of period at Sep. 30, 2021 152,797       $ 11       629,090       0   (476,304)  
Balance at end of period (in shares) at Sep. 30, 2021         113,324,000                      
Balance at beginning of period at Dec. 31, 2021 $ 179,620       $ 11       650,518       0   (470,909)  
Balance at beginning of period (in shares) at Dec. 31, 2021 114,452,000       114,452,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation $ 10,862               10,862              
Issuance of common stock upon exercise of stock options (in shares)         404,000                      
Issuance of common stock upon exercise of stock options 17               17              
Issuance of common stock upon vesting of restricted stock awards (in shares)         129,000                      
Issuance of common stock upon vesting of restricted stock units (in shares)         4,816,000                      
Issuance of common stock upon vesting of restricted stock units 1       $ 1                      
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)         1,874,000                      
Withholding of restricted stock units to satisfy tax withholding obligations upon the vesting of restricted stock units (3,616)               (3,616)              
Net loss (19,988)                           (19,988)  
Balance at end of period at Mar. 31, 2022 166,896       $ 12       657,781       0   (490,897)  
Balance at end of period (in shares) at Mar. 31, 2022         117,927,000                      
Balance at beginning of period at Dec. 31, 2021 $ 179,620       $ 11       650,518       0   (470,909)  
Balance at beginning of period (in shares) at Dec. 31, 2021 114,452,000       114,452,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of common stock upon exercise of stock options (in shares) 638,000                              
Repurchase and retirement of common stock (in shares) (14,603)                              
Repurchase and retirement of common stock $ (30)                           (30)  
Other comprehensive income (loss) 0                              
Net loss (59,314)                              
Balance at end of period at Sep. 30, 2022 $ 133,413       $ 12       663,654       0   (530,253)  
Balance at end of period (in shares) at Sep. 30, 2022 118,906,000       118,906,000                      
Balance at beginning of period at Mar. 31, 2022 $ 166,896       $ 12       657,781       0   (490,897)  
Balance at beginning of period (in shares) at Mar. 31, 2022         117,927,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation 3,365               3,365              
Issuance of common stock upon exercise of stock options (in shares)         180,000                      
Issuance of common stock upon exercise of stock options 8               8              
Issuance of common stock upon vesting of restricted stock awards (in shares)         27,000                      
Issuance of common stock upon vesting of restricted stock units (in shares)         520,000                      
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)         201,000                      
Withholding of restricted stock units to satisfy tax withholding obligations upon the vesting of restricted stock units (444)               (444)              
Net loss (26,278)                           (26,278)  
Balance at end of period at Jun. 30, 2022 143,547       $ 12       660,710       0   (517,175)  
Balance at end of period (in shares) at Jun. 30, 2022         118,453,000                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-based compensation 3,423               3,423              
Issuance of common stock upon exercise of stock options (in shares)         54,000                      
Issuance of common stock upon exercise of stock options 12               12              
Issuance of common stock upon vesting of restricted stock awards (in shares)         22,000                      
Issuance of common stock upon vesting of restricted stock units (in shares)         633,000                      
Withholding of restricted stock to satisfy tax withholding obligations upon the vesting of the related restricted stock (in shares)         241,000                      
Withholding of restricted stock units to satisfy tax withholding obligations upon the vesting of restricted stock units $ (491)               (491)              
Repurchase and retirement of common stock (in shares) (14,603)       (15,000)                      
Repurchase and retirement of common stock $ (30)                           (30)  
Other comprehensive income (loss) 0                              
Net loss (13,048)                           (13,048)  
Balance at end of period at Sep. 30, 2022 $ 133,413       $ 12       $ 663,654       $ 0   $ (530,253)  
Balance at end of period (in shares) at Sep. 30, 2022 118,906,000       118,906,000